GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (BSP:W2ST34) » Definitions » Cash Flow for Dividends

West Pharmaceutical Services (BSP:W2ST34) Cash Flow for Dividends : R$-325 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is West Pharmaceutical Services Cash Flow for Dividends?

West Pharmaceutical Services's cash flow for dividends for the three months ended in Dec. 2024 was R$-93 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was R$-325 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

West Pharmaceutical Services's quarterly payment of dividends increased from Jun. 2024 (R$-79 Mil) to Sep. 2024 (R$-80 Mil) and increased from Sep. 2024 (R$-80 Mil) to Dec. 2024 (R$-93 Mil).

West Pharmaceutical Services's annual payment of dividends declined from Dec. 2022 (R$-284 Mil) to Dec. 2023 (R$-279 Mil) but then increased from Dec. 2023 (R$-279 Mil) to Dec. 2024 (R$-361 Mil).


West Pharmaceutical Services Cash Flow for Dividends Historical Data

The historical data trend for West Pharmaceutical Services's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Cash Flow for Dividends Chart

West Pharmaceutical Services Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -247.46 -288.97 -283.78 -279.29 -360.57

West Pharmaceutical Services Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -72.52 -73.20 -78.64 -80.30 -93.35

West Pharmaceutical Services Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-325 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


West Pharmaceutical Services Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.


West Pharmaceutical Services Business Description

Traded in Other Exchanges
Address
530 Herman O. West Drive, Exton, PA, USA, 19341-1147
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

West Pharmaceutical Services Headlines

No Headlines